Anavex Life Sciences Corp.

NasdaqGS:AVXL Stock Report

Mkt Cap: US$847.4m

Anavex Life Sciences Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average management tenure


CEO

Chris Missling (56 yo)

9.58yrs

Tenure

US$6,753,643

Compensation

Dr. Christopher U. Missling, also known as the Chris, MS, Ph D., MBA, has been the Chief Executive Officer and President at Anavex Life Sciences Corp. since July 05, 2013 and had been its Chief Financial O...


CEO Compensation Analysis

How has Chris Missling's remuneration changed compared to Anavex Life Sciences's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022US$7mUS$586k

-US$48m

Jun 30 2022n/an/a

-US$45m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021n/an/a

-US$41m

Sep 30 2021US$9mUS$550k

-US$38m

Jun 30 2021n/an/a

-US$32m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020n/an/a

-US$28m

Sep 30 2020US$2mUS$550k

-US$26m

Jun 30 2020n/an/a

-US$26m

Mar 31 2020n/an/a

-US$26m

Dec 31 2019n/an/a

-US$26m

Sep 30 2019US$3mUS$513k

-US$26m

Jun 30 2019n/an/a

-US$26m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018n/an/a

-US$20m

Sep 30 2018US$3mUS$500k

-US$17m

Jun 30 2018n/an/a

-US$17m

Mar 31 2018n/an/a

-US$18m

Dec 31 2017n/an/a

-US$14m

Sep 30 2017US$3mUS$500k

-US$13m

Jun 30 2017n/an/a

-US$15m

Mar 31 2017n/an/a

-US$13m

Dec 31 2016n/an/a

-US$14m

Sep 30 2016US$11mUS$305k

-US$15m

Compensation vs Market: Chris's total compensation ($USD6.75M) is above average for companies of similar size in the US market ($USD3.83M).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Christopher Missling
Chairman9.58yrsUS$6.75m1.31%
$ 11.1m
Sandra Boenisch
Principal Financial Officer & Treasurer7.33yrsUS$452.50k0.029%
$ 249.6k
Stephan Toutain
Chief Operating Officer4.92yrsno datano data
Walter Kaufmann
Chief Scientific Officer1.08yrsno datano data
Emmanuel Fadiran
Senior Vice President of Regulatory Affairsno datano datano data
Clint Tomlinson
VP of Corporateno datano datano data
Adebayo Laniyonu
Senior Vice President of Nonclinical Development1.75yrsno datano data
Edward Hammond
Chief Medical Officer1.08yrsno datano data

3.3yrs

Average Tenure

56yo

Average Age

Experienced Management: AVXL's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christopher Missling
Chairman9.58yrsUS$6.75m1.31%
$ 11.1m
Jeffrey Cummings
Member of the Scientific Advisory Board11.92yrsno datano data
Jacqueline French
Member of the Scientific Advisory Board7.92yrsno datano data
Paul Aisen
Member of the Scientific Advisory Board12yrsno datano data
John Harrison
Member of the Scientific Advisory Board9.17yrsno datano data
Ottavio Arancio
Member of the Scientific Advisory Board9.25yrsno datano data
Tangui Maurice
Member of the Scientific Advisory Boardno datano datano data
Athanasios Skarpelos
Independent Director10.08yrsUS$407.12k1.68%
$ 14.2m
Norman Relkin
Member of the Scientific Advisory Board8.75yrsno datano data
Corinne Lasmézas
Member of the Scientific Advisory Board7.92yrsno datano data
Steffen Thomas
Independent Director7.67yrsUS$407.12kno data
Claus van der Velden
Lead Independent Director4.92yrsUS$423.12kno data

9.2yrs

Average Tenure

56yo

Average Age

Experienced Board: AVXL's board of directors are considered experienced (9.2 years average tenure).